Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 301-310 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Rapid Effects of Aldosterone. Relevant in Cardiac Ischemia?
Martin Wehling
Hypertension published June 13, 2005, doi:10.1161/01.HYP.0000171161.60967.ab [Abstract]  

Scientific Contributions
Endothelin-1 (1-31) Is an Intermediate in the Production of Endothelin-1 After Big Endothelin-1 Administration In Vivo
Marie-Hélène Fecteau, Jean-Claude Honoré, Mirco Plante, Julie Labonté, Giles A. Rae, and Pedro D’Orléans-Juste
Hypertension published June 13, 2005, doi:10.1161/01.HYP.0000170460.24604.23 [Abstract]  

Original Articles
Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II–Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats
Rong Wu, Marc-André Laplante, and Jacques de Champlain
Hypertension 2005;45:1139-1144; published online before print as doi:10.1161/01.HYP.0000164572.92049.29 [Abstract] [Full text]  

Hypertension Grand Rounds
Baroreflex Failure
Karsten Heusser, Jens Tank, Friedrich C. Luft, and Jens Jordan
Hypertension 2005;45:834-839; published online before print as doi:10.1161/01.HYP.0000160355.93303.72 [Abstract] [Full text]  

Original Articles
Carvedilol Reduces Plasma 8-Hydroxy-2'-Deoxyguanosine in Mild to Moderate Hypertension: A Pilot Study
Juyong Lee, Mejeong Lee, Jeong-Uk Kim, Kyung Il Song, Yun Seok Choi, and Sang-Sig Cheong
Hypertension 2005;45:986-990; published online before print as doi:10.1161/01.HYP.0000164569.63160.24 [Abstract] [Full text]  

Scientific Contributions
Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II-Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats
Rong Wu, Marc-André Laplante, and Jacques de Champlain
Hypertension published April 25, 2005, doi:10.1161/01.HYP.0000164572.92049.29 [Abstract]  

Scientific Contributions
Carvedilol Reduces Plasma 8-Hydroxy-2'-Deoxyguanosine in Mild to Moderate Hypertension. A Pilot Study
Juyong Lee, Mejeong Lee, Jeong-Uk Kim, Kyung Il Song, Yun Seok Choi, and Sang-Sig Cheong
Hypertension published April 18, 2005, doi:10.1161/01.HYP.0000164569.63160.24 [Abstract]  

Scientific Contributions
Baroreflex Failure
Karsten Heusser, Jens Tank, Friedrich C. Luft, and Jens Jordan
Hypertension published April 18, 2005, doi:10.1161/01.HYP.0000160355.93303.72 [Abstract]  

Editorial Commentaries
Beneficial Effects of Circulating Progenitor Endothelial Cells Activated by Angiotensin Receptor Antagonists
Bernard I. Levy
Hypertension 2005;45:491-492; published online before print as doi:10.1161/01.HYP.0000159196.10515.b5 [Full text]  

Original Articles
Modafinil Elicits Sympathomedullary Activation
Indu Taneja, Andre Diedrich, Bonnie K. Black, Daniel W. Byrne, Sachin Y. Paranjape, and David Robertson
Hypertension 2005;45:612-618; published online before print as doi:10.1161/01.HYP.0000158267.66763.63 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment